Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA

被引：0
|
作者：
Arash Mostaghimi
Jason Xenakis
Aster Meche
Timothy W. Smith
David Gruben
Vanja Sikirica
机构：
[1] Harvard Medical School,Department of Dermatology, Brigham and Women’s Hospital
[2] Pfizer Inc,undefined
[3] Pfizer Inc,undefined
[4] Pfizer Inc,undefined
来源：
Dermatology and Therapy | 2022年 / 12卷
关键词：
Alopecia areata; Autoimmune; Economic burden; Healthcare costs; Healthcare resource utilization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1027 / 1040
页数：13
相关论文
共 50 条
  • [21] Healthcare Resource Use and Costs Among Individuals with Vitiligo and Psychosocial Comorbidities: Retrospective Analysis of an Insured US Population
    Lofland, Jennifer H.
    Darbha, Samyuktha
    Naim, Ahmad B.
    Rosmarin, David
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2024, 16 : 557 - 565
  • [22] CHARACTERISING THE ECONOMIC BURDEN ASSOCIATED WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: HEALTHCARE RESOURCE USE AND COSTS IN ENGLAND
    Osman, F.
    Zema, C. L.
    Hurst, M.
    Sandler, B.
    Brellier, F.
    Utuama, O.
    Kirichek, O.
    Houghton, J.
    Lemmer, T.
    Tome, Esteban M.
    VALUE IN HEALTH, 2023, 26 (12) : S50 - S50
  • [23] Healthcare resource use and economic burden of respiratory illness among extremely preterm infants in the Netherlands
    Houben, Eline
    Siffel, Csaba
    Overbeek, Jetty
    Penning-van Beest, Fernie
    Sarda, Sujata P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 300 - 300
  • [24] IMPACT OF ANTIFIBROTIC USE ON HEALTHCARE RESOURCE USE AND COST IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) IN A COMMERCIALLY INSURED PATIENT POPULATION
    Corral, Mitra
    Deyoung, Kathryn
    Kong, Amanda
    CHEST, 2019, 156 (04) : 1137A - 1137A
  • [25] Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
    Thompson, Andrew R.
    Tziotzios, Christos
    Nesnas, John
    Randall, Rowena
    Czachorowski, Maciej
    Messenger, Andrew G.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (06) : 924 - 935
  • [26] A systematic literature review of the economic and healthcare resource burden of cytomegalovirus
    Diaz-Decaro, John
    Myers, Evan
    Mucha, Jacek
    Neumann, Monika
    Lewandowski, Witold
    Kaczanowska, Magdalena
    Schmidt, Elvira
    Natenshon, Andrew
    Talarico, Carla
    Buck, Philip O.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (07) : 973 - 986
  • [27] Assessment of The High risk and unmEt Need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource use, cost, and burden of illness in a commercially insured population
    Wittbrodt, Eric
    Bhalla, Narinder
    Sundell, Karolina Andersson
    Hunt, Phillip
    Wong, Nathan D.
    Kuster, Marco
    Mellstrom, Carl
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (04)
  • [28] Economic burden and co-morbidities of atrial fibrillation in a privately insured population
    Wu, EQ
    Birnbaum, EG
    Mareva, M
    Tuttle, E
    Castor, AR
    Jackman, W
    Ruskin, J
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (10) : 1693 - 1699
  • [29] The Economic Burden Of Osteoarthritis In Americans: Analysis From a Privately Insured Population.
    Wang, Susanne X.
    Ganguli, Arijit X.
    Macaulay, Dendy
    Reichmann, William
    Medema, Jeroen
    Cifaldi, Mary A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S424 - S424
  • [30] PREVALENCE AND HEALTHCARE UTILIZATION BURDEN ASSOCIATED WITH RHINOSINUSITIS IN A UNITED STATES COMMERCIALLY INSURED POPULATION
    Khanna, R.
    Holy, C. E.
    Romano, A.
    VALUE IN HEALTH, 2017, 20 (05) : A349 - A349
12345